Suchergebnisse - "Curtin, Nicola"

PubPharm (25)

1

Evaluating the potential of kinase inhibitors to suppress DNA repair and sensitise ovarian cancer cells to PARP inhibitors

enthalten in: Biochemical pharmacology | 2019

von Mukhopadhyay, A. | Drew, Y. | Matheson, E. | +4

2

Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von McCormick, A. | Donoghue, P. | Dixon, M. | +6

3

PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia

enthalten in: Oncotarget | 2015

von Herriott, A. | Tudhope, S. | Junge, G. | +13

4

Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition

enthalten in: Oncotarget | 2015

von Middleton, F. | Patterson, M. | Elstob, C. | +9

5

Development of pharmacodynamic biomarkers for ATR inhibitors

enthalten in: Molecular oncology | 2015

von Chen, T. | Middleton, F. | Falcon, S. | +3

6

Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma

enthalten in: Current opinion in oncology | 2014

von Vormoor, B. | Curtin, N.

7

DNA repair dysregulation from cancer driver to therapeutic target

enthalten in: Nature reviews. Cancer | 2012

von Curtin, N.

8

Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K

enthalten in: Molecular cancer therapeutics | 2012

von Munck, J. | Batey, M. | Zhao, Y. | +15

9

Nucleoside transport inhibitors : structure-activity relationships for pyrimido[5,4-d]pyrimidine derivatives that potentiate pemetrexed cytotoxicity in the presence of α1-acid glycoprotein

enthalten in: Journal of medicinal chemistry | 2011

von Saravanan, K. | Barlow, H. | Barton, M. | +7

10

Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2

enthalten in: Journal of the National Cancer Institute | 2011

von Drew, Y. | Mulligan, E. | Vong, W. | +9